Innovative Therapies for treating diseases are being sought after with fresh vigor as new targets, approaches and biology is discovered. One field which is poised to bring a paradigm change in the way diseases are treated in the next decades is the Stem cell therapy/Regenerative Medicine space. The number of companies and products in the clinic have reached a critical mass warranting a close watch for those interested in keeping pace with the development of new medicines.

The Regenerative medicine Universe is large and new companies are being added to it rapidly. As a result we have used some filters to select a few names for targets, detailed coverage in our Outlook this year.

Key Criteria for Our Selection are:-

• Uniqueness of the Technology platform and the ability to scale up commercially in case of positive outcome of products in the pipeline
• Pipeline and clinical data analysis
• Marketed product and commercial tie up. Robustness of the Management, financial and business model.